Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
OSE Immuno (OSE FP)
Watchlist
36
Analysis
Health Care
•
France
OSE Immunotherapeutics SA is a biotechnology company based in France, developing immunotherapy products against invasive/metastatic late-stage cancers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
OSE Immuno
•
27 Jul 2024 13:10
•
Issuer-paid
OSE Immunotherapeutics - Lusvertikimab shines in Phase II UC trial
OSE Immunotherapeutics’ run of positive news continues with the announcement of encouraging data from the Phase II proof-of-concept CoTikiS study,...
Edison Investment Research
Follow
311 Views
Share
bullish
•
OSE Immuno
•
27 Jun 2024 19:12
•
Issuer-paid
OSE Immunotherapeutics - Another partnership with expansion into CAR-T
OSE Immunotherapeutics has entered into a commercial and revenue sharing agreement with the Memorial Sloan Kettering Cancer Center (MSK), focused...
Edison Investment Research
Follow
223 Views
Share
bullish
•
OSE Immuno
•
06 Jun 2024 19:10
•
Issuer-paid
OSE Immunotherapeutics - Strong momentum in deal flow
OSE Immunotherapeutic’s FY24 has started off with a series of major wins, significantly bolstering the company’s clinical pipeline and liquidity....
Edison Investment Research
Follow
241 Views
Share
bullish
•
OSE Immuno
•
24 May 2024 01:10
•
Issuer-paid
OSE Immunotherapeutics - Another partnership win – Boehringer Ingelheim
OSE Immunotherapeutics has announced a considerable expansion of its partnership with Boehringer Ingelheim (BI), including the start of two new...
Edison Investment Research
Follow
271 Views
Share
bullish
•
OSE Immuno
•
19 Apr 2024 13:10
•
Issuer-paid
OSE Immunotherapeutics - AbbVie deal clears antitrust hurdle
OSE has announced that its licence agreement with AbbVie has cleared antitrust review and has become effective. As previously noted, this is...
Edison Investment Research
Follow
432 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x